Caris & Co Upgrades Eclipsys (ECLP) to Above Average
More News related to ECLP
- Eclipsys to Present at the Piper Jaffray 21st Annual Health Care Conference
- Eclipsys Marks 50 Millionth Order at Sarasota Memorial Health Care System
- Singapore General Hospital Activates Eclipsys' Sunrise Patient Flow
- Caris & Co Upgrades Eclipsys (ECLP) to Above Average
- After-Hours Movers 11/05: JSDA, ENOC, SAM, RST, ASEI, KFN Higher; MOVE, FNM, CROX, BEBE, BID Lower
Caris & Co upgrades Eclipsys (Nasdaq: ECLP) from Average to Above Average. Price target increased from $18 to $23.
To see more analyst ratings on ECLP Click Here.
Eclipsys Corporation operates as a healthcare information technology company in North America, the southeast Asia, and the Middle East.
Related Categories
UpgradesStocks Mentioned
-0.77Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
